Skip to main content

Military Health System

Military Medical Research Leads to 18 New Cancer Drugs, other Devices

Image of a patient prepares for a PET scan. Michelle Pribble, Naval Medical Center San Diego's lead nuclear medicine technologist, prepares a patient for a positron emission tomography (PET) scan in the hospital's Nuclear Medicine Department Oct. 6. A PET scan is used for revealing or evaluating conditions including brain disorders (Photo by: Navy Mass Communication Specialist Seaman Luke Cunningham)

Recommended Content:

Research & Innovation | Medical Research and Development

In just the past year, they've been working on new, high-tech treatments for major health problems like cancer, severe hearing loss and genetic diseases like muscular dystrophy.

While the Congressionally Directed Medical Research Programs, known as CDMRP, is not really a household name that is immediately familiar to many people in the military community, it is well known among medical researchers around the world.

The CDMRP is essentially a Department of Defense funding organization that has been a hub of cutting-edge healthcare innovation financing since the early 1990s and has impacted health care development inside and outside the military for decades.

"Certainly, when CDMRP research leads to Food and Drug Administration-approved treatment, it is a big win for the entire community," said Army Col. Sarah Goldman, CDMRP's director.

"Research from CDMRP's cancer programs alone has led to 18 FDA-approved drugs and devices that are currently being used, as well as significant changes in clinical practice."

Based at Fort Detrick, Maryland, the CDMRP is officially a part of the U.S. Army Futures Command, Medical Research and Development Command.

In just the last year, the FDA approved drugs developed through CDMRP-backed research to treat neurofibromatosis (a genetic disorder of the nervous system); Duchenne muscular dystrophy; and a blood cancer called multiple myeloma.

The CDMRP originated in 1992 via a single Congressional appropriation to encourage novel approaches to breast cancer research. Since then, it's grown to include funding for about 5,000 research projects investigating an array of medical issues.

"Our programs work hard to gather a lot of information to help identify research gaps and determine how to make key investments," Goldman said. "We gather different stakeholders at the table, to include representatives from the DOD. Many of our programs have NIH representation as well as experts from the VA (Veterans Administration) ... really all of the major federal and non-federal research funders. We also include scientists and clinical experts in a particular area, and it's extremely important that we have the consumer perspective at the table. Integrating consumers into CDMRP's panels is one of our hallmarks and their input is absolutely critical.

"Our programs conduct a funding landscape analysis, where we figure out what's been funded so far, and where the gaps are."

Teams then develop strategies on how to fill those research gaps. Certain funding mechanisms seek out "innovative, high-impact, high-risk, and high-gain projects, where we're willing to take a chance on some research" and where other agencies may not be willing to tread, Goldman said.

Some of the research may be exploratory in nature, she said. Sometimes reviewers of the research do not know who the principal investigator is, or even the organization behind it, to avoid bias toward some of the larger, more well-known performers.

"They can really focus on the idea, and help determine if it's innovative and potentially impactful or not," Goldman said.

Air Force spouse posing for a photo during her battle with cancer
Heather Souders, an Air Force spouse, poses for a photo during her battle with cancer after her diagnosis in 2018. The CDMRP has funded numerous research studies to develop new treatments for breast cancer (Photo by: Audra Flanagan)

In this context, "consumers" could be patients, survivors, family members, or advocates representing an entire community affected by the disease or condition that's being studied.

"Integrating the consumer viewpoint is really one of the central tenets of the CDMRP," said Rebecca Fisher, the organization's deputy director for program management. "It's something that CDMRP pioneered many, many years ago, and I think others are now starting to see the tremendous value in that. We worked with the VA a few years back to share CDMRP approaches to help with their efforts to integrate more veteran input into VA research. Consumers are active in every part of our process."

That includes patients or advocates helping to set strategies, helping with peer and programmatic reviews, and even participating in research projects with investigators. The CDMRP has a training program and a mentoring process for those consumers who participate and provide input.

"CDMRP is not here to fund research for research's sake," said Fisher, who has managed complex biomedical research programs within the DOD for more than 15 years. "We are focused on accelerating solutions that will better people's lives. Even if it's earlier stage work that we're supporting, we're always looking to that horizon and how we can get there faster."

Fisher said that CDMRP-funded open research awards currently number about 5,000. With so many highly promising areas being studied, it is difficult for her to pick just a handful of the most exciting prospects. But one that was cited by both Fisher and Goldman is a study of the drug known as Ruxolitinib for the possible prevention of breast cancer.

"If this drug is successful, it could have a major impact for women who are diagnosed with early benign breast lesions, when they don't know which ones are actually going to transition to cancers," Fisher explained. "Right now, the current standard of care is an anti-estrogen therapy, which has a lot of side effects and is very difficult, so some women discontinue or don't even take it.

"If you have a better preventative you can offer, it's a sea change in treatment. That's a huge, exciting project that's been developing over many years with different award mechanisms for these investigators through CDMRP's breast cancer program."

There is also a relatively new hearing restoration program underway that is funding pioneering research in treatment of auditory injuries and the restoration of hearing, including novel human 3D stem cell models of the inner ear, Fisher said.

"The inner ear is just really hard to get into and one of only a few organs for which biopsies are not possible," she said. "It's very difficult because of the bone structure around it. Having a way to test the effects of therapeutics on regenerating important sensory cells in the ear and perhaps restore hearing, down the road ... this technological development may open up those avenues. This could be a huge change in this field."

In 2019, the Nobel Prize in Physiology or Medicine was awarded to two doctors, Gregg Semenza and William Kaelin, Jr., who previously received funding from the CDMRP. They shared the award with another scientist for discovering how cells sense and adapt to oxygen availability. Their work has implications for treating a variety of diseases, including cancer.

"It was so exciting for CDMRP be a part of their journey on to winning the Nobel Prize, and to see how their research has led to tremendous innovative breakthroughs," Goldman said recently.

Previously, two other scientists who were CDMRP-funded during their careers went on to become Nobel laureates, one in 2008 and another in 2009.

"We have the opportunity to realize a vision for very specific areas of medical research need, and hopefully accelerate the achievement of products and outcomes that will help to improve the lives of service members, veterans, and the American public, and really make a difference," Fisher said.

"That's what CDMRP is here for. While we fund the whole spectrum of research, we're looking at that impact. That is number one in our book."

You also may be interested in...

Frontline Expeditionary Dental Care is Near-Time Reality

Article Around MHS
1/26/2023
Field Portable Dental System

U.S. Army Medical Materiel Development Activity’s Warfighter Deployed Medical Systems is working to modernize several field deployable dental treatment systems to provide dental treatments to warfighters in a not-so typical way.

Recommended Content:

Dental Health | Research & Innovation

U.S. Army Medical Laboratory Forges Relationship with Australian Defence Force Institute

Article Around MHS
1/25/2023
Military personnel in medical laoratory

American soldiers from the 1st Area Medical Laboratory were hosted by their counterparts at the Australian Defence Force Malaria and Infectious Disease Institute in Brisbane, Australia. Find out what was discussed at this meeting to strengthen critical relationships, save lives, and enable both sides' mission readiness.

Recommended Content:

Building Partner Capacity and Interoperability | Health Readiness & Combat Support | Research & Innovation

Genome Sequencing Assists Research at Naval Health Research Center

Article
1/24/2023
Lab technicians doing genome research

Learn how unique samples from naval vessels, US-Mexico border populations, and DOD beneficiaries aided in the Naval Health Research Center’s sequencing efforts.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

U.S. Military HIV Research Lends Lessons Learned to COVID-19

Article
1/19/2023
Gloved hands working in laboratory

The U.S. military has engaged in HIV research for three decades, contributing critical lessons learned, knowledge, and expertise during the COVID-19 research and vaccine development effort.

Recommended Content:

Coronavirus & the MHS Response | DOD HIV/AIDS Prevention Program | Research & Innovation | Coronavirus

Naval Medical Research Center Uses Genome Sequencing for Variants

Article
1/12/2023
Military personnel pose for a group photo

NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

DOD Aims to Shield Warfighters From Novel Biological Agents

Article Around MHS
1/11/2023
Military personnel in chemical cloud

Newer and more complicated biological battlefield threats are prompting the need for stronger countermeasures. We explain the DOD's new advances in medical countermeasures - including cutting edge technology and artificial intelligence - to keep the warfighters operational and combat ready.

Recommended Content:

Research & Innovation | Chemical and Biological Exposures

“Call for Abstracts” Opens for 2023 MHS Research Symposium

Article
1/10/2023
Attendees enjoying the 2022 MHSRS scientific poster presentation

Preparations for the 2023 MHSRS are currently underway! Learn how you can qualify to present at the DOD's premier scientific meeting for the unique medical needs of the warfighter. (Deadline for abstracts: Feb. 19th)

Recommended Content:

Research & Innovation | MHS Research Symposium

USAMRIID Focuses on Genome Sequencing to Detect Variants

Article
1/5/2023
Military medical personnel in laboratory

A connected family of laboratories across the MHS allows a more rapid response to the outbreak.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

Uniformed Services University Professor Develops Self-Diagnosis, Treatment Kit for Common Female Infections

Article Around MHS
1/4/2023
USU infographic with Dr. Elizabeth Kostas-Polston

It's a major research advancement in women's health and females serving in the U.S. military may soon have access to it. See how a new, self-diagnosis and self-treatment kit can help deployed women overseas or in austere environments.

Recommended Content:

Uniformed Services University of the Health Sciences | Research & Innovation | Women's Health

Air Force Research Laboratory Launches Wearable Biomolecular Sensors Program

Article Around MHS
12/29/2022
Military personnel demonstrating a wearable human performance monitoring device

It's like an aircraft's "black box" - that Soldiers wear. Learn about the research collaboration that will literally "arm" warfighters with a sensor to track their well-being during critical missions, predicting performance and health issues before they occur.

Recommended Content:

Research & Innovation | Health Care Technology

Naval Medical Research Center Begins Phase 1 Testing of Diarrhea Vaccine

Article Around MHS
12/29/2022
Research scientist in laboratory

The Naval Medical Research Center partners with the National Institute of Health’s National Institute of Allergy and Infectious Diseases to begin testing of a new vaccine. Find out how it could protect Soldiers against a debilitating conditions that often impair the ability to do their jobs.

Recommended Content:

Medical Research and Development | Vaccine-Preventable Diseases

Whole Genome Sequencing at Tripler Army Medical Center

Article
12/29/2022
Dr. Keith Fong reviews data with other lab technicians

The third installment in a 6-part series highlighting the efforts of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Coronavirus & the MHS Response | Research & Innovation | Coronavirus

Tele-Critical Care Brings New Capability to Womack Army Medical Center

Article Around MHS
12/27/2022
Military medical personnel demonstrating new tele-critical care medicine

This groundbreaking new tool gives critically ill patients access to 24/7 monitoring by deploying medical experts who can get them help immediately. See how it works, and why military medical experts are calling it the fail-safe mechanism that cannot be underestimated.

Recommended Content:

Telehealth Program | Health Care Technology | Research & Innovation

Defense Threat Reduction Agency Celebrates Opening of New Training Center

Article Around MHS
12/27/2022
Defense Threat Reduction Agency members

It's been eight years in the making! Now, learn more about this ceremonial culmination of a large, global collaboration toward preventing future disease outbreaks and biological threats.

Recommended Content:

Research & Innovation | Building Partner Capacity and Interoperability | Biological Threat Reduction Program | Ebola

Walter Reed Army Institute of Research Implements SARS-CoV-2 Genome Sequencing

Article
12/23/2022
Military medical personnel in laboratory

This is the second article in a 6-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Global Health Engagement | Coronavirus & the MHS Response | Research & Innovation
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 10
Refine your search
Last Updated: January 24, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery